1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
12 |
| Hold |
1 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | June 2026 | |
|---|---|---|
| Revenue | 8.44M | 3.45% |
| Gross profit | 6.18M | 6.84% |
| Net profit | -3.87M | 334.29% |
| EBITDA | -2.93M | 215.16% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €18.51M |
Number of shares | 3.14M |
52-week high/low | €17.89 - €5.16 |
| Dividends | No |
Beta | 1.34 |
P/E ratio | -1.19 |
PEG ratio | 0.02 |
P/B ratio | -28.64 |
P/S ratio | 0.58 |
Company profile
| Name | CytoSorbents |
| CEO | Phillip Chan |
| Employees | 129 |
Discover assets
Shareholders of CytoSorbents also invest in the following assets
